CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Toevoegen aan een lijst
|
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| - CHF | -.--% |
|
-.--% | -.--% |
Grafiek agenda Charles River Laboratories International, Inc.
4a6ba39d9195f319acc9beda58860f.PaNaDHIp2zfjZ_aY2krYhoOKihTeZ4ey12OKFzJ2rTU.Rdk1IUsQk2C2BaL2o3qU3q7N2WfqSr6F4AHEegsewlQN-yxtPlqYXtMvuw~9f316c751e77009058feeedd34a4c39b
Komende gebeurtenissen op Charles River Laboratories International, Inc.
Gebeurtenissen op naam
| 09-05-2024 14:30 | Q1 2024 Presentatie van de resultaten |
| 09-05-2024 13:00 | Q1 2024 Cijferpublicaties |
| 08-05-2024 14:00 | Algemene vergadering |
| 09-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:6181 |
| 09-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:5467 |
| 09-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:5315 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4703 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4413 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4224 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4191 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4186 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:4182 |
| 09-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:3975 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2841 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2840 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2835 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2714 |
| 08-04-2024 22:30 | American Association for Cancer Research Meeting - Poster No:2630 |
| 08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:2053 |
| 08-04-2024 18:00 | American Association for Cancer Research Meeting - Poster No:2020 |
Geschiedenis van de jaarlijkse publicaties
| Start boekjaar | december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 2 621 2 614 0.28% | 2 924 2 891 1.15% | 3 540 3 522 0.52% | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 4 221 |
|
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | 604 597 1.28% | 701 693 1.26% | 879 878 0.22% | 991 982 0.87% | 1 013 1 017 -0.4% | 1 062 |
|
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | 497 489 1.64% | 585 575 1.73% | 742 738 0.51% | 834 820 1.67% | 839 842 -0.35% | 874 |
|
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | 304 284 7.16% | 447 394 13.45% | 481 449 7.01% | 623 568 9.63% | 581 513 13.41% | 534 |
|
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | 252 240 4.84% | 364 296 23% | 391 358 9.2% | 486 409 18.85% | 475 387 22.66% | 406 |
|
WPA USD | Gepubliceerd Verwachting Spread | 5,07 4,85 4.57% | 7,20 5,88 22.44% | 7,60 6,99 8.67% | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 7,91 |
| Datum van publicatie | 11/02/20 | 17/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - |
Geschiedenis van de driemaandelijkse publicaties
| Start boekjaar | december | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 914 909 0.58% | 973 995 -2.22% | 989 970 1.93% | 1 100 1 035 6.26% | 1 029 986 4.39% | 1 060 1 054 0.59% | 1 027 1 000 2.61% | 1 013 991 2.24% | 1 012 993 1.82% | 1 023 | 1 069 | 1 114 | 1 088 | 1 103 |
|
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | 233 233 0.02% | 250 247 1.36% | 240 238 1.14% | 267 260 2.72% | 260 252 3.03% | 260 258 0.62% | 255 241 5.8% | 239 242 -1.38% | 233 222 4.94% | 244 | 283 | 304 | 263 | 273 |
|
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | 196 194 1.26% | 212 208 1.97% | 201 197 2.26% | 225 213 5.33% | 218 209 3.98% | 216 213 1.41% | 211 194 8.51% | 194 196 -1% | 187 178 5.43% | 197 | 235 | 254 | 224 | 233 |
|
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | 111 149 -25.64% | 144 142 1.83% | 123 128 -3.67% | 245 155 57.85% | 131 150 -12.47% | 129 143 -10.32% | 113 120 -6.11% | 209 120 74.62% | 99,0 96,3 2.82% | 110 | 156 | 169 | 150 | 157 |
|
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | 93,0 109 -14.63% | 109 110 -0.34% | 96,5 98,4 -1.95% | 187 109 71.19% | 103 102 0.7% | 97,0 105 -7.26% | 87,4 88,9 -1.74% | 187 92,4 102.53% | 67,3 71,2 -5.45% | 89,4 | 115 | 131 | 109 | 119 |
|
WPA USD | Gepubliceerd Verwachting Spread | 1,81 2,07 -12.39% | 2,13 2,13 -0.04% | 1,88 1,84 2.12% | 3,65 2,14 70.86% | 2,01 1,99 0.87% | 1,89 2,04 -7.23% | 1,69 1,68 0.51% | 3,62 1,78 103.94% | 1,30 1,35 -3.7% | 1,73 | 2,25 | 2,56 | 2,08 | 2,26 |
| Datum van publicatie | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 11/05/23 | 09/08/23 | 08/11/23 | 14/02/24 | 09/05/24 | - | - | - | - | - |
| 15-07-2024 07:45 | ADDLIFE AB: Q2 2024 Cijferpublicaties |
| 22-07-2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Cijferpublicaties (schatting) |
| 24-07-2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Cijferpublicaties (schatting) |
| 24-07-2024 | ALKERMES PLC: Q2 2024 Cijferpublicaties (schatting) |
| 24-07-2024 | IQVIA HOLDINGS INC.: Q2 2024 Cijferpublicaties (schatting) |
| 24-07-2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Cijferpublicaties (schatting) |
| 25-07-2024 | LONZA GROUP AG: Q2 2024 Cijferpublicaties |
| 25-07-2024 07:00 | BACHEM HOLDING AG: Q2 2024 Cijferpublicaties |
| 26-07-2024 | PHARVARIS N.V.: Q2 2024 Cijferpublicaties (schatting) |
| 26-07-2024 07:00 | BB BIOTECH AG: Q2 2024 Cijferpublicaties |
Gebeurtenissen in het verleden in de sector Charles River Laboratories International, Inc.
| 29-05-2024 22:01 | IMMUNOVANT, INC.: Q4 2024 Cijferpublicaties |
| 23-05-2024 13:00 | CUREVAC N.V.: Q1 2024 Cijferpublicaties |
| 22-05-2024 07:00 | EVOTEC SE: Q1 2024 Cijferpublicaties |
| 21-05-2024 23:14 | ALVOTECH: Q1 2024 Cijferpublicaties |
| 21-05-2024 13:00 | EXSCIENTIA PLC: Q1 2024 Cijferpublicaties |
| 17-05-2024 08:00 | BIOARCTIC AB: Q1 2024 Cijferpublicaties |
| 15-05-2024 22:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties |
| 15-05-2024 13:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties |
| 15-05-2024 | GNI GROUP LTD.: Q1 2024 Cijferpublicaties |
| 14-05-2024 22:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties |
